Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 160,205 | 0 | 93,991 | 0 | 96,013 |
| Cost of Goods | 55,469 | N/A | 54,739 | N/A | 43,479 |
| Gross Profit | 104,736 | N/A | 39,252 | N/A | 52,534 |
| Operating Expenses | 237,217 | 0 | 108,174 | 0 | 109,832 |
| Operating Income | -132,012 | N/A | -68,183 | N/A | -56,819 |
| Other Income | 11,126 | 0 | 8,395 | 0 | -5,676 |
| Pre-tax Income | -120,886 | 0 | -59,788 | 0 | -62,495 |
| Income Tax | 4,435 | N/A | 5 | N/A | -288 |
| Net Income Continuous | -125,321 | N/A | -59,793 | N/A | -62,207 |
| Net Income | $-125,321 | $N/A | $-59,793 | $N/A | $-62,207 |
| EPS Basic Total Ops | -0.68 | N/A | -0.32 | N/A | -0.34 |
| EPS Basic Continuous Ops | -0.68 | N/A | -0.33 | N/A | -0.34 |
| EPS Diluted Total Ops | -0.68 | N/A | -0.32 | N/A | -0.34 |
| EPS Diluted Continuous Ops | -0.68 | N/A | -0.33 | N/A | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.05 | -0.16 | -0.40 | N/A |
| EBITDA(a) | $-128,105 | $N/A | $-62,461 | $N/A | $-56,819 |